These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 17214578)

  • 41. Type I Interferons in Systemic Lupus Erythematosus: A Journey from Bench to Bedside.
    Sim TM; Ong SJ; Mak A; Tay SH
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269647
    [TBL] [Abstract][Full Text] [Related]  

  • 42. JAK inhibitor has the amelioration effect in lupus-prone mice: the involvement of IFN signature gene downregulation.
    Ikeda K; Hayakawa K; Fujishiro M; Kawasaki M; Hirai T; Tsushima H; Miyashita T; Suzuki S; Morimoto S; Tamura N; Takamori K; Ogawa H; Sekigawa I
    BMC Immunol; 2017 Aug; 18(1):41. PubMed ID: 28830352
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interferon response to dipyridamole in lupus erythematosus patients.
    Konstantinov K; Galabov A; Mastikova M
    Br J Dermatol; 1989 Jul; 121(1):59-63. PubMed ID: 2757956
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway.
    Higgs BW; Liu Z; White B; Zhu W; White WI; Morehouse C; Brohawn P; Kiener PA; Richman L; Fiorentino D; Greenberg SA; Jallal B; Yao Y
    Ann Rheum Dis; 2011 Nov; 70(11):2029-36. PubMed ID: 21803750
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Type I interferon blockade in systemic lupus erythematosus: where do we stand?
    Lauwerys BR; Ducreux J; Houssiau FA
    Rheumatology (Oxford); 2014 Aug; 53(8):1369-76. PubMed ID: 24344319
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anifrolumab in systemic lupus erythematosus: current knowledge and future considerations.
    Anderson E; Furie R
    Immunotherapy; 2020 Apr; 12(5):275-286. PubMed ID: 32237942
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of interferons in SLE.
    Bengtsson AA; Rönnblom L
    Best Pract Res Clin Rheumatol; 2017 Jun; 31(3):415-428. PubMed ID: 29224681
    [TBL] [Abstract][Full Text] [Related]  

  • 48. TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis.
    Bodewes ILA; Huijser E; van Helden-Meeuwsen CG; Tas L; Huizinga R; Dalm VASH; van Hagen PM; Groot N; Kamphuis S; van Daele PLA; Versnel MA
    J Autoimmun; 2018 Jul; 91():97-102. PubMed ID: 29673738
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibody against chromatin assembly factor-1 is a novel autoantibody specifically recognized in systemic lupus erythematosus.
    Doe K; Nozawa K; Hiruma K; Yamada Y; Matsuki Y; Nakano S; Ogasawara M; Nakano H; Ikeda T; Ikegami T; Fujishiro M; Kawasaki M; Ikeda K; Amano H; Morimoto S; Ogawa H; Takamori K; Sekigawa I; Takasaki Y
    Lupus; 2014 Sep; 23(10):1031-41. PubMed ID: 24836587
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interferon-induced 2'-5' adenylate synthetase in vivo and interferon production in vitro by lymphocytes from systemic lupus erythematosus patients with and without circulating interferon.
    Preble OT; Rothko K; Klippel JH; Friedman RM; Johnston MI
    J Exp Med; 1983 Jun; 157(6):2140-6. PubMed ID: 6189954
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interferon-directed therapies for the treatment of systemic lupus erythematosus: a critical update.
    Chaichian Y; Strand V
    Clin Rheumatol; 2021 Aug; 40(8):3027-3037. PubMed ID: 33411137
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies.
    Bengtsson AA; Sturfelt G; Truedsson L; Blomberg J; Alm G; Vallin H; Rönnblom L
    Lupus; 2000; 9(9):664-71. PubMed ID: 11199920
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Blockade of interferon-γ normalizes interferon-regulated gene expression and serum CXCL10 levels in patients with systemic lupus erythematosus.
    Welcher AA; Boedigheimer M; Kivitz AJ; Amoura Z; Buyon J; Rudinskaya A; Latinis K; Chiu K; Oliner KS; Damore MA; Arnold GE; Sohn W; Chirmule N; Goyal L; Banfield C; Chung JB
    Arthritis Rheumatol; 2015 Oct; 67(10):2713-22. PubMed ID: 26138472
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of Long Interspersed Nuclear Element 1 Retroelements and Induction of Type I Interferon in Patients With Systemic Autoimmune Disease.
    Mavragani CP; Sagalovskiy I; Guo Q; Nezos A; Kapsogeorgou EK; Lu P; Liang Zhou J; Kirou KA; Seshan SV; Moutsopoulos HM; Crow MK
    Arthritis Rheumatol; 2016 Nov; 68(11):2686-2696. PubMed ID: 27338297
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A promising approach to targeting type 1 IFN in systemic lupus erythematosus.
    Chaichian Y; Wallace DJ; Weisman MH
    J Clin Invest; 2019 Mar; 129(3):958-961. PubMed ID: 30776023
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Type 1 interferon activation in systemic sclerosis: a biomarker, a target or the culprit.
    Kakkar V; Assassi S; Allanore Y; Kuwana M; Denton CP; Khanna D; Del Galdo F
    Curr Opin Rheumatol; 2022 Nov; 34(6):357-364. PubMed ID: 36125916
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relationship between circulating interferon and anti-interferon antibodies and impaired natural killer cell activity in systemic lupus erythematosus.
    Sibbitt WL; Gibbs DL; Kenny C; Bankhurst AD; Searles RP; Ley KD
    Arthritis Rheum; 1985 Jun; 28(6):624-9. PubMed ID: 2408630
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An update on the role of type I interferons in systemic lupus erythematosus and Sjögren's syndrome.
    Thorlacius GE; Wahren-Herlenius M; Rönnblom L
    Curr Opin Rheumatol; 2018 Sep; 30(5):471-481. PubMed ID: 29889694
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus.
    Blomberg S; Eloranta ML; Magnusson M; Alm GV; Rönnblom L
    Arthritis Rheum; 2003 Sep; 48(9):2524-32. PubMed ID: 13130472
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interleukin-17 in systemic lupus erythematosus: A comprehensive review.
    Li D; Guo B; Wu H; Tan L; Chang C; Lu Q
    Autoimmunity; 2015; 48(6):353-61. PubMed ID: 25894789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.